Toprol
Pricing Report NDC 0186-1088-05

Latest NADAC: $1.25562 per EA · Effective Dec 23, 2020 · Est. package price $125.56 (100 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Toprol Xl (NDC 0186-1088-05) is $1.25562 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 23, 2020.

As a provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 100 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.25562
Per EA

Effective Date
Dec 23, 2020
Billable Units
100 EA
Estimated Package Price
$125.56
Data Status
As of Jan 06, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.12384 (Effective: Dec 23, 2020)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.14824 to $1.26283 per EA. Over this 7 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.1482 - $1.2628
Market Volatility
9.98% Variance
Latest Trend
0.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 23, 2020 $1.25562 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 23, 2020 $1.25562 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 18, 2020 $1.25529 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026